Fig. 2From: COVID-19 related outcomes among individuals with neurodegenerative diseases: a cohort analysis in the UK biobankRisk of COVID-19 among individuals with any or specific neurodegenerative disease, compared to individuals without such a condition. a Analyses were adjusted for birth year, sex, race/ethnicity, body mass index, smoking, alcohol use, Townsend deprivation index, annual household income, educational attainment, and Charlson Comorbidity Index (dementia excluded). b Any COVID-19 includes a positive test result from Public Health England, an inpatient diagnosis from UK Biobank inpatient hospital data, or a death concerning COVID-19 infectionBack to article page